Nakamura Yuka 中村由香

… Alternative Names

中村由香ナカムラユカ

NAKAMURA Yuka 中村由香

Less

Researcher Number	80364595
Affiliation (Current)	2025: 獨協医科大学, 医学部, 講師
Affiliation (based on the past Project Information) *help	2016 – 2021: 獨協医科大学, 医学部, 講師 2010 – 2013: 獨協医科大学, 医学部, 講師
Review Section/Research Field	Principal Investigator Hematology Except Principal Investigator Hematology / Basic Section 54010:Hematology and medical oncology-related
Keywords	Principal Investigator ニッチ因子 / 骨髄微小環境 / 白血病幹細胞 / 白血病モデルマウス Except Principal Investigator 遺伝子 / 癌 / 内科 / ヒストン脱アセチル化酵素阻害剤 / SKP2 / 急性巨核芽球性白血病 … More / t(3;21) / RUNX1-EVI1 / 分子標的療法 / 発現制御 / 中心体 / CD41 / 骨髄異形成 / 血小板増多 / レポーター・アッセイ / miRNA / MDS / 予後不良 / 全生存 / 定量PCR法 / Taqman法 / AML / miR-9 / glvcophorin A / ALAS-E / β-グロビン / ベンチジン / エリスロポエチン / UT-7/GM / MIR-9 / 白血病 / マウス / ES / MIR9 / microRNA / EVI1 / RUNX1 / TEL Less

Molecular pathogenesis and molecular therapy in RUNX1-EVI1-type leukemia.
- Principal Investigator
  
  Mitani Kinuko
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Dokkyo Medical University
Analysis of molecular mechanisms in RUNX1-EVI1-type leukemia
- Principal Investigator
  
  Mitani Kinuko
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Dokkyo Medical University
Analysis of leukemic microenvironment in RUNX1/EVI1 mouse modelPrincipal Investigator
- Principal Investigator
  
  NAKAMURA Yuka
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Dokkyo Medical University
Analysis of mechanisms in hematopoietic regulation by transcription factors
- Principal Investigator
  
  MITANI Kinuko
- Project Period (FY)
  2008 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Hematology
- Research Institution
  Dokkyo Medical University

All 2022 2021 2018 2017 2016 2013 2012 2010

All Journal Article Presentation

[Journal Article] Emergence of t(3;21)(q26.2;q22) during eltrombopag treatment in a patient with relapsed aplastic anemia who received chemotherapy for angioimmunoblastic T-cell lymphoma.2022
- Author(s)
  Nakamura F, Nakamura Y, Nannya Y, Arai H, Shimbo K, Nakamura Y, Seo S, Sasaki K, Ichikawa M, Ogawa S, Mitani.
- Journal Title
  
  Leukemia Research Reports
  
  Volume: 17 Pages: 100305-100305
- DOI
  10.1016/j.lrr.2022.100305
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08822
[Journal Article] Development of Philadelphia chromosome-negative acute myeloid leukemia with IDH2 and NPM1 mutations in a patient with chronic myeloid leukemia who showed a major molecular response to tyrosine kinase inhibitor therapy.2021
- Author(s)
  Nakamura F, Arai H, Nannya Y, Ichikawa M, Furuichi S, Nagasawa F, Takahashi W, Handa T, Nakamura Y, Tanaka H, Nakamura Y, Sasaki K, Miyano S, Ogawa S, Mitani K.
- Journal Title
  
  Int J Hematol
  
  Volume: 113 Issue: 6 Pages: 936-940
- DOI
  10.1007/s12185-020-03074-7
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08822, KAKENHI-PROJECT-19H05656
[Journal Article] PECAM is an effective and safe anthracycline-containing regimen for patients with relapsed or refractory non-Hodgkin lymphoma.2021
- Author(s)
  Nakamura　F, Arai　H, Tokita　K, Furuichi　S, Sugita-Nagasawa　F, Takahashi　W, Handa　T, Iso　H, Tadokoro　J, Tsurumi　S, Nakamura　Y, Nakamura　Y, Sasaki　K, Seo　S, Ichikawa　M, Mitani K.
- Journal Title
  
  Leukemia & Lympho
  
  Volume: 62 Issue: 1 Pages: 239-242
- DOI
  10.1080/10428194.2020.1817442
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08822
[Journal Article] RUNX1-EVI1 induces dysplastic hematopoiesis and acute leukemia of the megakaryocytic lineage in mice.2018
- Author(s)
  Nakamura Y, Ichikawa M, Oda H, Yamazaki I, Sasaki K, Mitani K.
- Journal Title
  
  Leukemia Res
  
  Volume: 74 Pages: 14-20
- DOI
  10.1016/j.leukres.2018.09.015
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K09858
[Journal Article] Chronic myelogenous leukemia in chronic phase transforming into acute leukemia under treatment with dasatinib 4 months after diagnosis.2016
- Author(s)
  Nakamura Y, Tokita T, Nagasawa F, Takahashi W, Nakamura Y, Sasaki K, Ichikawa M, Mitani K.
- Journal Title
  
  Int J Hematol.
  
  Volume: 103 Issue: 3 Pages: 348-353
- DOI
  10.1007/s12185-015-1909-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K09858
[Journal Article] Somatic mosaicism in chronic myeloid leukemia in remission.2016
- Author(s)
  Mitani K, Nagata Y, Sasaki K, Yoshida K, Chiba K, Tanaka H, Shiraishi Y, Miyano S, Makishima H, Nakamura Y, Nakamura Y, Ichikawa M, Ogawa S.
- Journal Title
  
  Blood.
  
  Volume: 128 Issue: 24 Pages: 2863-2866
- DOI
  10.1182/blood-2016-06-723494
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PLANNED-15H05909, KAKENHI-PROJECT-26221308, KAKENHI-PROJECT-16K09858
[Journal Article] Overexpression of MIR9 indicates poor prognosis in acute lymphoblastic leukemia2013
- Author(s)
  Sugita F, Maki K, Nakamura Y, Sasaki K, Mitani K
- Journal Title
  
  Leuk Lymphoma
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591406
[Journal Article] Enhanced Angpt1/Tie2 signaling affects the differentiation and long-term repopulation ability of hematopoietic stem cells2013
- Author(s)
  Ikushima YM, Arai F, Nakamura Y, Hosokawa K, Kubota Y, Hirashima M, Toyama H, Suda T
- Journal Title
  
  Biochem Biophys Res Commun
  
  Volume: 430(1) Pages: 20-5
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591406
[Journal Article] Fadd and Skp2 are possible downstream targets of RUNX1-EVI12013
- Author(s)
  Maki K, Sugita F, Nakamura Y, Sasaki K, Mitani K
- Journal Title
  
  Int J Hematol
  
  Volume: 97(1) Pages: 83-91
- NAID
  10031144638
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591406
[Journal Article] Acute myeloid leukemia with t(7;21)(q11.2;q22) expresses a novel, reversed-sequence RUNX1-DTX2 chimera2012
- Author(s)
  Maki K, Sasaki K, Sugita F, Nakamura Y, Mitani K
- Journal Title
  
  Int J Hematol
  
  Volume: 96(2) Pages: 268-73
- NAID
  10031043088
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591406
[Journal Article] Aberrant expression of MIR9 indicates poor prognosis in acute myeloid leukaemia2012
- Author(s)
  Maki K, Yamagata T, Sugita F, Nakamura Y, Sasaki K, Mitani K
- Journal Title
  
  Br J Haematol
  
  Volume: 158(2) Pages: 283-5
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591406
[Journal Article] 骨髄異形成症候群の染色体・遺伝子異常と予後2010
- Author(s)
  中村由香、三谷絹子
- Journal Title
  
  血液・腫瘍科 61
  
  Pages: 398-402
- Data Source
  KAKENHI-PROJECT-20390275
[Presentation] RUNX1-EVI1 キメラ遺伝子による白血病モデルマウスの解析.2017
- Author(s)
  中村由香、市川幹、小田秀明、山崎家春、佐々木光、三谷絹子
- Organizer
  第54回日本臨床分子医学会学術集会
- Data Source
  KAKENHI-PROJECT-16K09858
[Presentation] RUNX1-EVI1 fusion gene induces an acute megakaryoblastic leukemia in mice.2016
- Author(s)
  Yuka Nakamura, Motoshi Ichikawa, Ieharu Yamazaki, Ko Sasaki, Kinuko Mitani
- Organizer
  第78回日本血液学会学術集会
- Place of Presentation
  パシフィコ横浜（神奈川県、横浜市）
- Year and Date
  2016-10-13
- Data Source
  KAKENHI-PROJECT-16K09858

1. MITANI Kinuko (50251244)

# of Collaborated Projects: 3 results

# of Collaborated Products: 8 results
2. 佐々木光 (60282638)

# of Collaborated Projects: 3 results

# of Collaborated Products: 7 results
3. 市川幹 (60463840)

# of Collaborated Projects: 2 results

# of Collaborated Products: 7 results
4. 牧和宏 (50337391)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. 山形哲也 (30424047)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 小川誠司

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
7. 牧島秀樹

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Nakamura Yuka 中村 由香

中村 由香 ナカムラ ユカ

NAKAMURA Yuka 中村 由香

Research Projects

Research Products

Co-Researchers

Molecular pathogenesis and molecular therapy in RUNX1-EVI1-type leukemia.

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Analysis of molecular mechanisms in RUNX1-EVI1-type leukemia

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analysis of leukemic microenvironment in RUNX1/EVI1 mouse modelPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analysis of mechanisms in hematopoietic regulation by transcription factors

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Emergence of t(3;21)(q26.2;q22) during eltrombopag treatment in a patient with relapsed aplastic anemia who received chemotherapy for angioimmunoblastic T-cell lymphoma.2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Development of Philadelphia chromosome-negative acute myeloid leukemia with IDH2 and NPM1 mutations in a patient with chronic myeloid leukemia who showed a major molecular response to tyrosine kinase inhibitor therapy.2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] PECAM is an effective and safe anthracycline-containing regimen for patients with relapsed or refractory non-Hodgkin lymphoma.2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] RUNX1-EVI1 induces dysplastic hematopoiesis and acute leukemia of the megakaryocytic lineage in mice.2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Chronic myelogenous leukemia in chronic phase transforming into acute leukemia under treatment with dasatinib 4 months after diagnosis.2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Somatic mosaicism in chronic myeloid leukemia in remission.2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Overexpression of MIR9 indicates poor prognosis in acute lymphoblastic leukemia2013

Author(s)

Journal Title

Data Source

[Journal Article] Enhanced Angpt1/Tie2 signaling affects the differentiation and long-term repopulation ability of hematopoietic stem cells2013

Author(s)

Journal Title

Data Source

[Journal Article] Fadd and Skp2 are possible downstream targets of RUNX1-EVI12013

Author(s)

Journal Title

NAID

Data Source

[Journal Article] Acute myeloid leukemia with t(7;21)(q11.2;q22) expresses a novel, reversed-sequence RUNX1-DTX2 chimera2012

Author(s)

Journal Title

NAID

Data Source

[Journal Article] Aberrant expression of MIR9 indicates poor prognosis in acute myeloid leukaemia2012

Author(s)

Nakamura Yuka 中村由香

中村由香ナカムラユカ

NAKAMURA Yuka 中村由香